Amarin Balance Sheet Health
Financial Health criteria checks 6/6
Amarin has a total shareholder equity of $531.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $750.6M and $219.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$305.73m |
| Equity | US$531.38m |
| Total liabilities | US$219.24m |
| Total assets | US$750.62m |
Recent financial health updates
We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth
Jul 18
Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?
Nov 11Recent updates
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues
Oct 29Amarin Corporation plc (NASDAQ:AMRN) Shares Could Be 29% Above Their Intrinsic Value Estimate
Aug 01Amarin Corporation plc's (NASDAQ:AMRN) 28% Dip In Price Shows Sentiment Is Matching Revenues
Jun 06Amarin Corporation: Small Signs Of Recovery May Not Be Enough
Apr 16Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding
Mar 12Amarin: Sarissa Is Giving Me Hope Again
Jan 15Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified
Jan 03Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)
Nov 19Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel
Sep 27We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth
Jul 18Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?
Nov 11Amarin gains as activist Sarissa starts process for special meeting to replace some board members
Oct 11Amarin down 21% on higher than normal daily volume
Aug 22For Amarin, Something Wishful This Way Comes
Aug 14Amarin Q2 2022 Earnings Preview
Aug 02HLS Therapeutics gets reimbursement for Vascepa in Ontario
Jul 25Financial Position Analysis
Short Term Liabilities: AMRN's short term assets ($650.2M) exceed its short term liabilities ($201.6M).
Long Term Liabilities: AMRN's short term assets ($650.2M) exceed its long term liabilities ($17.7M).
Debt to Equity History and Analysis
Debt Level: AMRN is debt free.
Reducing Debt: AMRN has no debt compared to 5 years ago when its debt to equity ratio was 10.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AMRN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: AMRN has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 2.6% each year